DNS 005
Alternative Names: DNS-005Latest Information Update: 10 Oct 2023
At a glance
- Originator Dart NeuroScience
- Class Nootropics; Small molecules
- Mechanism of Action Cyclic AMP response element-binding protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Cognition disorders
Most Recent Events
- 10 Oct 2023 DNS 005 is still in preclinical development for cognition disorders in USA (Dart NeuroScience pipeline, October 2023)
- 28 Jan 2022 No recent reports of development identified for preclinical development in Cognition-disorders in USA
- 03 Feb 2020 DNS 005 is available for licensing as of 03 Feb 2020. http://www.dartneuroscience.com/